Hybrid 3D/2D Convolutional Neural Network for Hemorrhage Evaluation on Head CT.
Hybrid 3D/2D Convolutional Neural Network for Hemorrhage Evaluation on Head CT.
复制标题
DOI:
10.3174/ajnr.a5742
复制
发表时间:
2018-09
期刊:
影响因子:
--
通讯作者:
Chow D
中科院分区:
文献类型:
--
作者:
Chang PD;Kuoy E;Grinband J;Weinberg BD;Thompson M;Homo R;Chen J;Abcede H;Shafie M;Sugrue L;Filippi CG;Su MY;Yu W;Hess C;Chow D
Convolutional neural networks (CNN) are a powerful technology for image recognition. This study evaluates a CNN optimized for the detection and quantification of intraparenchymal (IPH), epidural/subdural (EDH/SDH) and subarachnoid (SAH) hemorrhages on non-contrast CT (NCCT). This study was performed in two phases. First, a training cohort of all NCCTs acquired at a single institution between January 1, 2017 and July 31, 2017 was used to develop and cross-validate a custom hybrid 3D/2D mask R-CNN architecture for hemorrhage evaluation. Second, the trained network was applied prospectively to all NCCTs ordered from the emergency department between February 1, 2018 and February 28, 2018 in an automated inference pipeline. Hemorrhage detection accuracy, AUC, sensitivity, specificity, PPV, and NPV was assessed for full and balanced datasets, and further stratified by hemorrhage type and size. Quantification was assessed by Dice score coefficient and Pearson correlation. A total of 10,159-exam training cohort (512,598 images; 901/8.1% hemorrhages) and 862-exam test cohort (23,668 images; 82/12% hemorrhags) were used in this study. Accuracy, area under the curve, sensitivity, specificity, PPV, and NPV for hemorrhage detection were 0.975, 0.983, 0.971, 0.975, 0.793, and 0.997 upon training cohort cross-validation, and 0.970, 0.981, 0.951, 0.973, 0.829, and 0.993 for the prospective test set. Dice scores for IPH, EDH/SDH, and SAH were 0.931, 0.863 and 0.772, respectively. A customized deep learning tool is accurate in detection and quantification of hemorrhage on NCCT. Demonstrated high performance on prospective NCCTs ordered from the emergency department suggests the clinical viability of the proposed deep learning tool.